Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
ETH Singapore Sec Ltd. seeks a dedicated postdoctoral researcher to lead the RELab tenoexo development for a clinic-to-home rehabilitation trial.
You will supervise PhD students, coordinate clinical evaluation, and collaborate with NTU, TTSH, and community partners. Responsibilities include planning technical developments, coordinating large-scale multi-arm studies, ensuring ethics and regulatory compliance, and disseminating results at conferences and in journals.
Stroke remains a leading cause of disability worldwide. Although improved early stroke response has reduced mortality, it has also produced a growing population of stroke survivors, intensifying the demand for long-term rehabilitation and placing a substantial clinical and economic burden on healthcare systems. Because today's neurorehabilitation model relies heavily on resource-intensive, therapist-led care, meeting this demand will require scalable, cost-effective solutions that extend beyond the clinic and into the home. To address these needs, the first phase of the Future Health Technologies Programme (FHT1) at the Singapore-ETH Centre (SEC) (https://fht.ethz.ch) developed and piloted innovative upper limb rehabilitation technologies and evaluated them in clinical settings, both in hospital and in the homes of post-stroke subjects. Building on this foundation, FHT2 aims to scale up these technologies and carry out more extensive clinical evaluation, paving the way for technology-based clinic-to-home rehabilitation to be integrated into Singapore's healthcare system. Specifically, one of our projects focuses on the development of a soft robotic hand exoskeleton (RELab tenoexo) to enhance upper limb rehabilitation sessions in the clinic (therapy scenario) and allow for additional task-oriented training at home (assistance scenario). A first version of the soft exoskeleton has been developed within FHT1 and a proof-of-concept trial demonstrated preliminary feasibility, with post-stroke subjects using the rehabilitation device at home. However, adherence to home rehabilitation without therapist supervision and support can be challenging, ultimately affecting therapy dose. Within FHT2, we will complement the exoskeleton with an AI-based digital health intervention, specifically an LLM-based conversational agent that will deliver support via a companion mobile app. The app will serve as both the user interface for daily interaction and support and a digital platform for data collection, remote monitoring, and telerehabilitation. We will also further investigate how neuromodulation could be combined to exoskeleton support in order to boost recovery after stroke. The impact of these technology developments will then be evaluated in the context of a multi-arm rehabilitation intervention at home in the context of a 6-week proof of value clinical trial.
As a postdoctoral researcher, you will be responsible for leading the research team focusing on the development of the RELab tenoexo system that will be used in the clinical trial (considering aspects from exoskeleton design improvement, software/gamification, intention detection approaches for control, interfacing with the accompanying digital app, data analyses, etc). You will coordinate the overall project and clinical evaluation of the system and will closely supervise the work of two PhD students working on specific aspects of exoskeleton design and digital intervention design. You will coordinate the clinical trials (e.g., ethics application, administrative tasks, reporting) and interaction with clinical partners and community partners involved in the project. The work will be performed in close collaboration with our research partners at Nanyang Technological University (NTU), Tan Tock Seng Hospital (TTSH), and community partners such as Stroke Support Station (S3).